Ingevity Corp Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Ingevity Corp stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Chemicals & Materials sector, Ingevity Corp has logged 181 insider filings. Market capitalisation: €2.6bn. The latest transaction was disclosed on 18 August 2026 (Cession). Among the most active insiders: PLATT PHILLIP JOHN. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,348 of 29,063 companies
FCF yld 11%
Earn yld -7.0%
EV/EBITDA ·
ROE 30%
Gross mgn 40%
Net mgn -14%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 August 2026
All Executives181 Thresholds0 Prospectus0 Other0
Declarations 181 total
▼ President & CEO · Executives · 14 Aug 2026
5,000 shares @ US$75.73 Common Stock SEC:0001436880-26-000008:0
▼ President & CEO · Executives · 17 Aug 2026
5,000 shares @ US$75.83 Common Stock SEC:0001436880-26-000008:1
▼ President & CEO · Executives · 18 Aug 2026
92 shares @ US$74.71 Common Stock SEC:0001436880-26-000008:2
▼ President & CEO · Executives · 12 Aug 2026
5,000 shares @ US$76.62 0.014% mcap 19.9% of flow Common Stock SEC:0001436880-26-000006:0
▼ President & CEO · Executives · 13 Aug 2026
5,000 shares @ US$75.73 0.014% mcap 19.7% of flow Common Stock SEC:0001436880-26-000006:1
● SVP, Chief Financial Officer · Executives · 10 Aug 2026
1,698 shares @ US$77.04 0.0049% mcap 22.6% of flow Common Stock SEC:0001668926-26-000006:0
▼ SVP, Gen. Counsel & Secretary · Executives · 3 Aug 2026
1,397 shares @ US$73.76 0.0041% mcap 33.8% of flow Common Stock SEC:0002017486-26-000005:0
▼ SVP, Gen. Counsel & Secretary · Executives · 3 Aug 2026
1,312 shares @ US$73.67 0.0038% mcap 31.7% of flow Common Stock SEC:0002017486-26-000005:1
● SVP, Chief Financial Officer · Executives · 24 Jul 2026
3,294 shares @ US$73.26 0.0095% mcap 54.7% of flow Common Stock SEC:0001653477-26-000041:0
● SVP, Gen. Counsel & Secretary · Executives · 6 Jul 2026
168 shares @ US$73.86 0.0005% mcap 16.6% of flow Common Stock SEC:0001653477-26-000039:0
◆ VP, Chief Accounting Officer · Executives · 22 Jun 2026
2,063 shares Common Stock SEC:0002142185-26-000004:0
▼ SVP, Chief HR Officer · Executives · 28 May 2026
266 shares @ US$68.45 0.0007% mcap 53.6% of flow Common Stock SEC:0001552446-26-000003:0
▼ SVP, Chief HR Officer · Executives · 28 May 2026
30 shares @ US$68.57 0.0001% mcap 6.1% of flow Common Stock SEC:0001552446-26-000003:1
▼ SVP, Chief HR Officer · Executives · 28 May 2026
200 shares @ US$68.53 0.0005% mcap 40.3% of flow Common Stock SEC:0001552446-26-000003:2
◆ Director · Executives · 30 Apr 2026
1,904 shares 0Common Stock SEC:0001653477-26-000024:0
◆ Director · Executives · 30 Apr 2026
1,904 shares 0Common Stock SEC:0001653477-26-000023:0
◆ Director · Executives · 30 Apr 2026
1,904 shares 0Common Stock SEC:0001531814-26-000001:0
◆ Director · Executives · 30 Apr 2026
1,904 shares 0Common Stock SEC:0001095670-26-000001:0
◆ Director · Executives · 30 Apr 2026
1,904 shares 0Common Stock SEC:0001575329-26-000004:0
◆ Director · Executives · 30 Apr 2026
1,904 shares 0Common Stock SEC:0001580705-26-000002:0
◆ Director · Executives · 30 Apr 2026
1,904 shares 0Common Stock SEC:0001938475-26-000002:0
◆ Director · Executives · 30 Apr 2026
1,904 shares 0Common Stock SEC:0002066872-26-000004:0
● President & CEO · Executives · 7 Apr 2026
3,574 shares @ US$70.57 21.4% of flow Common Stock SEC:0001436880-26-000004:1
● President & CEO · Executives · 7 Apr 2026
13,102 shares @ US$70.57 78.6% of flow Common Stock SEC:0001436880-26-000004:0
◆ Director · Executives · 1 Apr 2026
398 shares @ US$72.28 36.8% of flow Common Stock SEC:0001575329-26-000003:0
25 of 181 declarations
Load more (156 remaining) 关于 Ingevity Corp Ingevity Corp. (NYSE: NGVT) 是一家在美国上市的特种材料公司,总部位于美国南卡罗来纳州北查尔斯顿。该公司为严苛的工业应用开发先进的碳材料、工程材料、特种聚合物和特种化学品。其商业模式以技术差异化、客户配方支持和应用性能为中心,而非商品规模产量。Ingevity 目前报告三个运营部门:高性能材料、先进聚合物技术和高性能化学品。高性能材料包括用于排放控制和过滤的活性炭技术。先进聚合物技术包括用于涂料、粘合剂、弹性体和相关工业应用的己内酯基特种聚合物。高性能化学品涵盖特种化学品和路面技术,包括用于农业、基础设施和道路标记应用的产品。
Ingevity 的根源可追溯到 Westvaco 以及后来的 WestRock 的遗留业务。该公司于 2016 年 5 月分拆为一家独立的上市公司,这使其拥有悠久的工业传承,同时管理层能够围绕更高价值的专业业务来优化产品组合。Ingevity 还强调其底层技术平台拥有约 90 年的创新传承。如今,该集团表示在全球多个地点运营,支持北美和其他国际市场的地域多元化商业足迹。
从竞争角度来看,Ingevity 在特种化学品和材料领域占据利基市场地位。其优势在于技术进入壁垒、产品认证周期以及服务于性能、可靠性和法规遵从性至关重要的终端市场的能力。主要终端用途包括汽车零部件、排放捕获、沥青铺路、涂料、农用化学品、润滑剂、生物塑料和路面标记。这使得该公司面临多个终端市场,但也为其提供了一系列嵌入关键任务流程和基础设施的产品。
近期发展突显了积极的投资组合重塑努力。2025 年和 2026 年,Ingevity 通过剥离和对非核心业务的战略审查,包括与部分工业特种产品和道路标记活动相关的行动,继续精简其资产基础。该公司 2025 年的业绩显示,尽管宏观背景波动,但基础业务仍具韧性,而 2026 年初的更新证实,管理层仍专注于改善产品组合、降低复杂性并增强自由现金流生成。因此,对于投资者而言,NGVT 代表着一家在纽约证券交易所上市的特种材料公司,并具有重组角度:长期股权案例取决于执行力、利润纪律以及成功将投资组合重新定位到更高质量的专业应用。